Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03628638 · ClinicalTrials.gov registry record
Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 1,718
- Enrollment target
NCT03628638: Completed study, sponsored by Exact Sciences Corporation.
NCT03628638 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 1,718 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03628638 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 1,718 participants
- Enrollment target
Study Summary
The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.
Primary Outcome
Biomarkers under evaluation include differential methylation of nucleic acids and altered expression of proteins in blood to detect lung cancer
Interventions
- OTHER Blood Sample Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,718 participants |
| Start Date | 2017-04-06 |
| Est. Completion | 2021-01-31 |
What the finished NCT03628638 record still lists
NCT03628638 is an observational study that tracks outcomes without assigning an intervention. Its 1,718 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Blood Sample Collection is the first listed.
NCT03628638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03628638 about?
NCT03628638 is a clinical study titled "Blood Sample Collection in Subjects Participating in a Lung Cancer Screening Program". The primary objective of this study is to establish a control population to assess performance of an investigational diagnostic test targeting lung neoplasms.
What is the current status of trial NCT03628638?
This trial is currently completed. The enrollment target is 1,718 participants. The study started on 2017-04-06. Estimated completion is 2021-01-31.
What interventions are being tested in trial NCT03628638?
The interventions under investigation include: Blood Sample Collection (OTHER).
Who is sponsoring clinical trial NCT03628638?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04291612 · 1,715 participants
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
- NCT06898034 · 1,725 participants
Postpartum Ultrasound Evaluation to Assess Risk of Hemorrhage
- NCT05303636 · 1,710 participants · Phase 4
LF111 or Drospirenone Chew vs Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women
- NCT06413420 · 1,731 participants
SUNOSI® (Solriamfetol) Pregnancy Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI